Results for pharmaceuticals: 2165

By Tu Lei Servier, a France-based pharmaceutical company, plans to expand its presence in China and the Asia-Pacific region to boost its sales, said a senior company official Wednesday in Beijing. "As the second largest medicine producer in the world, we see an annual income of $5.5 billion, with...

Baring Asset Management Ltd, a global investment management firm, on Aug. 19 raised its H-share holding in Guangzhou Pharmaceutical Co Ltd<600332><0874> to 7.56% from the previous 6.07%, according to the bourse operator Hong Kong Exchanges and Clearing<0388>.HKEx said Baring Asset...

What we commonly known as active pharmaceutical ingredients (APIs) generally refer to chemicals which are used for the production of human drugs and which are the major drug ingredients before they are made into preparations; they are upstream products in the process of pharmaceutical production.

Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd.

China鈥檚 850 billion yuan ($124 billion) plan to provide basic health coverage for the vast majority of its 1.3 billion citizens by 2011 is creating opportunities for large drug makers, a specialist on China鈥檚 pharmaceutical market said. With sluggish growth in the United States and Europe, ma...

Joincare Pharmaceutical Group Industry Co<600380> has received approval from its board of directors to issue up to RMB 700 million in exchangeable bonds, sources reported. The bonds will be exchangeable for shares of Livzon Pharmaceutical Group Inc<000513><200513>, an affiliate of Joincare Pharmaceutical...

Baring Asset Management Ltd, a global investment management firm, has raised its H-share holding in Guangzhou Pharmaceutical Co Ltd<600332><0874> to 5.73% from the previous 3.26%, according to the bourse operator Hong Kong Exchanges and Clearing (HKEx)<0388>....

Zhuhai-based Livzon Pharmaceutical Group Inc<000513><200513> bought back 384,800 HK dollar-denominated B shares in April this year, according to the company's statement filed with the Shenzhen Stock Exchange on Tuesday.As of Apr. 30 2009, the company has repurchased a total of 7.2...

NEW YORK/LONDON, April 16 - The pharmaceutical industry is going back to the lab for its business models as it faces historic challenges. Large drugmakers are experimenting with various collaborations as their major products face...

Shenzhen-listed Jilin Pharmaceutical Co Ltd<000545>, a Chinese pharmaceutical raw materials manufacturer and seller, today announced that the company's board of directors plan to apply for bank loans of up to RMB 200 million before Jun. 30, 2010, the Shanghai Securities News reported....